Watch CBS News

Even stronger obesity drug could further upend weight-loss care

FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.